Science Highlights
Published on November 13, 2026
Gut Microbial Injury and Recovery After Allogeneic HCT
by Transplantation and Cellular Therapy
Kaundal S, Patil AN, Khatri P, et al. Early Gut Microbiome Metabolites and Diversity Predict Graft-Versus-Host Disease-Free Survival After Allogeneic Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 2026; (doi: 10.1016/j.jtct.2026.09.012).
Building on the hypothesis that a disrupted gut microbiome contributes to graft-versus-host disease (GVHD), researchers investigated the effect of gut microbial metabolic injury and impaired recovery soon after allogeneic hematopoietic cell transplantation (allo-HCT). The longitudinal, observational study included 62 patients, whose pre- and post-transplant stool samples facilitated analysis of the fecal short-chain fatty acids (SCFAs) butyrate, propionate, and acetate. The researchers theorized, and subsequently demonstrated, that depletion of those metabolites at week 2 and impaired recovery of microbial diversity by week 4 were associated with poor long-term GVHD-free survival (GFS), measured as survival absent grade II-IV acute GVHD, moderate–to-severe chronic GVHD, or death. During 2 years of follow-up, 43 participants (69%) missed the primary outcome of GFS, which improved in patients with higher concentrations of all three SCFAs and strong recovery of microbiome diversity. The findings suggest resilience to transplant-related injury, rather than microbial composition at baseline, informs downstream outcomes and that there is an opportunity early after HCT to introduce microbiome-targeted interventions to support favorable results.
Read more.
Transplantation and Cellular Therapy